Analytical Expertise

CRC provides a complete consultancy service to the pharmaceutical industry, offering innovative solutions to meet your decision-making and health outcomes needs.

CRC's core strength is the application of modern techniques to the fields of health economics, disease modelling and epidemiology:

CRC and Health Economics
We provide independent research, advisory and consultancy services on policy implications and economic issues within the pharmaceutical, health care and biotechnology sectors.
- Cost of illness analysis
- Cost utility analysis
- Cost effectiveness analysis
- Health Related Quality of Life
- Health Technology Assessment
- NICE appraisals
- Reimbursement agency appraisals
CRC and Disease Modelling
We excel in identifying complex inter-relationships within data, identifying trends and forecasting disease evolution utilizing advanced modelling techniques to manipulate and interpret data from a variety of sources.
- Deterministic and stochastic modeling
- Multivariate statistical analysis
- Advanced non-parametric multivariate techniques
- Advanced data visualisation techniques
- Generalised linear models
- Bayesian analysis
- Survival analysis
CRC and Epidemiology
CRC provides key skills in the study of the causes, distribution, and control of disease in populations.
- Burden of illness
- Hospital activity inpatients and outpatients
- Record Linkage
- Case-Control studies
- General Practitioner Research Database (GPRD) studies

Analyses performed

Listed below are some of the analyses performed by CRC in the past.

Please choose from the following areas:

Cardio

Analysis	Reports	Economic modelling
	(number of epidemiology, budget impact, patient resource usage, or quality of life reports)	Number of models	Type of model
Anticoagulation	3
Blood Transfusion	1	1	Markov
Chest Pain	1
LDL Aphesis	1	1	Simulation
Stroke Spasticity	2	1	Markov
UK Cardiovascular Risk	2	1	Simulation
Venous Thromboembolism	1

CNS

Analysis	Reports	Economic modelling
	(number of epidemiology, budget impact, patient resource usage, or quality of life reports)	Number of models	Type of model
Epilepsy	7
Migraine	1
Learning Disabilities	3
Parkinsons Disease	1
Restless Leg Syndrome	1

Diabetes

Analysis	Reports	Economic modelling
	(number of epidemiology, budget impact, patient resource usage, or quality of life reports)	Number of models	Type of model
Hypoglycaemia	2
Insulin Resistance	1
Metabolic Syndrome	1
Pre Diabetes	2	1	Simulation
Renal Dialysis	5	1	Decision Analytic
Diabetic Peripheral Neuropathy	3
Type 1 Diabetes Mellitus	2	2	Simulation
Type 2 Diabetes Mellitus	19	3	Simulation

Infection

Analysis	Reports	Economic modelling
	(number of epidemiology, budget impact, patient resource usage, or quality of life reports)	Number of models	Type of model
AIDS / HIV	1	1	Simulation
Fungal Infections	1
Hepatitis B	1	1	Markov
Antiobiotic Usage	4	1	Markov

Methodological

Analysis	Reports	Economic modelling
	(number of epidemiology, budget impact, patient resource usage, or quality of life reports)	Number of models	Type of model
Mapping Disease Specific QoL	5

NHS

Analysis	Reports	Economic modelling
	(number of epidemiology, budget impact, patient resource usage, or quality of life reports)	Number of models	Type of model
Delayed Treatment of Care	1	1	Simulation
Emergency Admissions Forecasting	1	1	Simulation
Hospital Bed Forecasting	1	1	Simulation
Hospital Capacity Planning	2	2	Simulation

Obesity

Analysis	Reports	Economic modelling
	(number of epidemiology, budget impact, patient resource usage, or quality of life reports)	Number of models	Type of model
Obesity	5	4	Simulation

Oncology

Analysis	Reports	Economic modelling
	(number of epidemiology, budget impact, patient resource usage, or quality of life reports)	Number of models	Type of model
Anaemia and Cancer	1
Breast Cancer	1
Cervical Cancer	1

Respiratory

Analysis	Reports	Economic modelling
	(number of epidemiology, budget impact, patient resource usage, or quality of life reports)	Number of models	Type of model
Asthma	1
COPD	3	1	Markov

Others

Analysis	Reports	Economic modelling
	(number of epidemiology, budget impact, patient resource usage, or quality of life reports)	Number of models	Type of model
Ankylosing Spondylitus	1
Crohn's Disease	1
Gastric Bleeding	1
Infertility	1	1	Simulation
Iron Deficiency	1
Liver Transplantation	2	1	Markov
Microprolactinomas	1
Ulceration	1
Urology	1
Bleeding Oesophageal Varices	1	1	Simulation
Growth Hormone Deficiency	2	1	Simulation
Psoriasis	2